Former drug developers cannot apply for registered stake betting appmedicines，Future，Personal or scientific institutions can directly obtain the drug approval number。August 10，Following the "Pilot Plan for the Pharmaceutical Located Permits held by the State Council" of the General Office of the State Council，After incorporating Sichuan and other 10 provinces (cities) into the pilot，Provincial Food and Drug Administration determined that Chengdu High -tech Zone、Wenjiang District, Chengdu、Luzhou Pharmaceutical Industrial Park、Meishan Economic Development Zone、Yuechi Pharmaceutical Industrial Park as a pilot work area for the pilot work of the province's pharmaceutical listing license holder，This indicates that the pharmaceutical industry in our province officially ushered in & ldquo; property rights revolution & rdquo;。

 

  According to the "Pilot Plan for the Organization of the Pharmaceutical Licensed Permit"，Sichuan Stake Sports Bettingdrug listing license and production license will be separated，Drug Scientific Research Institutions、Personnel will be able to apply for a drug listing independently，and cooperate with qualified enterprises to produce。This move will help motivate R & D personnel，Promote the marketization of drug research and development。Once there is a problem with the medicine，Consumers can at the same time to R & D staff、Production enterprises to make claims。

 

  Pilot holders to promote drug listing permit、Use supervision to help push the innovation and development of the pharmaceutical industry in our province，Provincial Food and Drug Administration also recently introduced the "Implementation Plan for the Top Ten Medical R & D Institutions in Sichuan Province", "Early Intertices Implementation Plan for Research and Development in Sichuan New Drugs"，Proposal will My stake betting appstart the approval of innovative drug reviews & ldquo; green channel & rdquo;，For major innovative medicines、First imitation、The variety of clinical urgently needed，Do not fall at the standard、Under the premise that the program is not diminished，Intervention in advance，Accelerate the listing of new drugs。Establishing a pharmaceutical institution innovation assistance system，Provide policy services and technical support for the clinical trials of innovative drugs。